Phase I study of weekly maytansine given by iv bolus or 24-hour infusion

Cancer Treat Rep. Nov-Dec 1979;63(11-12):1953-60.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bone Marrow / drug effects
  • Child
  • Digestive System / drug effects
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Parenteral
  • Injections, Intravenous
  • Liver / drug effects
  • Male
  • Maytansine / administration & dosage
  • Maytansine / therapeutic use*
  • Maytansine / toxicity
  • Middle Aged
  • Neoplasms / drug therapy*
  • Nervous System / drug effects
  • Oxazines / therapeutic use*

Substances

  • Oxazines
  • Maytansine